Post-Finasteride Syndrome: What the FDA and the Label Say

This page sets out what the FDA label says, what the FDA heard about topical products, what studies found, and what to do if you notice a change. We do not tell anyone to start or stop a medicine. That is a talk to have with your prescriber.

What post-finasteride syndrome means

Finasteride is a pill for male pattern hair loss. It lowers DHT, a hormone made from testosterone. Most men in the trials had no sexual side effects, and those who did usually saw them fade.

PFS describes something else. It is the label men and some doctors use when problems start on finasteride and go on after the drug is stopped. A 2026 review dates the term: "Post-finasteride syndrome (PFS), proposed in 2012, involves persistent sexual and neuropsychiatric adverse events (AEs) after cessation" (Gupta et al., Int J Dermatol, PubMed). In plain words: lasting sexual, mood and mental side effects after stopping.

The symptoms men describe most often fall into three groups:

• Sexual: low sex drive, trouble getting an erection, changes in ejaculation or orgasm.
• Mood: low mood, anxiety, and in some reports thoughts of suicide.
• Thinking and body: brain fog, tiredness, poor sleep, and testicle pain.

What the FDA label says

The Propecia label has two kinds of side effect data. Telling them apart is the key to this whole debate.

Trial data. In the first year of the hair loss trials, decreased libido was reported by 1.8% of men on the drug and 1.3% on a dummy pill. Erectile dysfunction was 1.3% against 0.7%. The label adds: "Resolution occurred in men who discontinued therapy with PROPECIA due to these side effects and in most of those who continued therapy" (DailyMed: Propecia label). In plain words: in the trials, these side effects went away for the men who stopped.

Reports after approval. The label's postmarketing list covers problems reported once the drug was on sale. It includes "sexual dysfunction that continued after discontinuation of treatment, including erectile dysfunction, libido disorders, ejaculation disorders, and orgasm disorders." Under mood it lists "depression, suicidal ideation and behavior." Suicidal ideation means thoughts of suicide.

The label is careful about what those reports prove. It says that "it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure." So the label confirms the reports exist, without saying how often or whether the drug caused them. Breast changes are a separate topic, covered in our finasteride gynecomastia guide.

Finasteride brain fog

Brain fog is not a word on the Propecia label. It does appear in an FDA alert. In April 2025, writing about compounded topical finasteride, the FDA said the reports it received "describe adverse events that are consistent with those reported in association with the approved oral finasteride products, such as erectile dysfunction, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, decreased libido and testicular pain" (FDA alert on compounded topical finasteride).

The same alert counted "32 cases reported to the FDA Adverse Event Reporting System between 2019 and 2024" and said "Most of the reports FDA has received state the adverse events continued to persist after product discontinuation." That alert is about compounded sprays and gels, which are not FDA-approved. Our topical vs oral finasteride guide covers that product type.

Are finasteride side effects permanent?

For most men in the trials, no. Side effects went away after stopping, and often even while staying on the drug. The open question is the smaller group who report problems that last.

Studies that support PFS. A 2011 study interviewed 71 men whose sexual problems lasted at least three months after stopping. The authors concluded: "Physicians treating MPHL should discuss the potential risk of persistent sexual side effects associated with finasteride" (Irwig and Kolukula, J Sex Med, PubMed). MPHL means male pattern hair loss. The authors also listed the study's limits, including "selection bias" and "recall bias."

A 2025 review concluded that men treated with finasteride "could develop a plethora of non-neglectable physical and psychological symptoms identifying PFS" (Cilio et al., Int J Impot Res, PubMed).

Studies that question PFS. A 2026 study followed men from a large prostate cancer prevention trial through Medicare records for a median of 20 years. It found that "Of the 22 conditions potentially related to PFS, none had a statistically significant association with treatment arm" (Till et al., Urology, PubMed). In plain words: men who took finasteride were no more likely to have these problems than men who took a dummy pill. That trial used the higher-strength prostate tablet, in older men.

So the honest answer is that it is not settled. The reports are real reports. Whether the drug causes lasting harm, and in how many men, has not been shown either way.

Finasteride side effects after stopping

Two different things can happen after stopping, and they get mixed up online.

Hair changes. This is expected. The Propecia label says "Withdrawal of treatment leads to reversal of effect within 12 months." In plain words: hair kept or regrown on the drug tends to be lost within a year of stopping. Our finasteride timeline shows the trial data.

Side effects that last. This is what PFS describes. The label lists such reports, as quoted above. The trials found side effects resolved in men who stopped.

Is finasteride withdrawal a real thing?

"Finasteride withdrawal" usually means one of the two things above. The label does not describe a withdrawal syndrome, such as the kind some drugs cause when stopped suddenly. What it describes is the loss of hair gains after stopping, and reports of side effects that continued. If you plan to stop, tell your prescriber, so you have a plan for your hair and a record of any symptoms.

What to do if you notice a change

• Tell your prescriber. Online programs let you message a clinician. Describe what changed and when it started.
• Mood changes matter most. If you have thoughts of harming yourself, call or text 988 in the US, the 988 Suicide and Crisis Lifeline, any time.
• Report it to the FDA. Anyone can file a side effect report through FDA MedWatch. The FDA alert asks consumers to do so.
• Bring a list. Note sleep, mood, sex drive and focus before and after, so a doctor has something to work with.

These programs let you message a clinician between visits:

From each program's own page, read 2026-11-02.

What finasteride costs

If you and your prescriber decide finasteride fits, the generic tablet starts at $14 a month online with the visit included. Ro, our top-scored program, charges $16 a month on a 12-month plan. Prices checked November 14, 2026. Every plan is on our hair loss price page, and programs are ranked on best programs. For the full trial table of side effects, see our finasteride side effects guide.

Sources and read dates

Each source below was read on November 14, 2026.

• DailyMed, Propecia label, revised 8/2022.
• FDA, alert on compounded topical finasteride, content current as of April 22, 2025.
• PubMed, Irwig and Kolukula, 2011; Cilio et al., 2025; Gupta et al., 2026; Till et al., 2026.